Wound bandage basing on lipidocolloid technology application experience in outpatient treatment of foot trophic ulcer
https://doi.org/10.14341/2306-3513-2011-1-29-33
Abstract
Foot trophic ulcer treatment in diabetic patients has significant value in amputation prophylactic. The aim of this study is to evaluate of comprehensive bandage materials employment in foot ulcer patients. Material and methods . Study includes 10 diabetic patients with neuropathic ulcers. Local treatment was conducted using bandages Urgosorb, Cellosorb MA, Urgotul SAG, Cellosorb Ag, Urgotul (Laboratories Urgo). Treatment protocol implied the extremity relief, ulcer defect processing with scalpel, antibacterial therapy in case of infection. There were estimated defect area dynamics, treatment duration, number of defects were healed during 8 weeks follo-up period. Results . Mean treatment duration before ulcer healing was 30.0 ± 9.1 days. Ulcer defects closed up in 6 of 9 patients who completed all treatment procedures. Three ulcers did not heal but defect area has shrunken up to 90,5% in compare to initial. Mean number of bandage changes during treatment was 15.4 ± 8.2. Defect surface median decreased from 113.2 (ranged 33,1 – 4013,1) mm2 to 38,4 (33,1–1351) mm2. There were no adverse effects regarding to bandages during treatment. Conclusion. In studied group of patients with foot trophic ulcer the application of bandages produced by Urgo Lab. revealed their atraumatics, good tolerance and satisfied efficiency in foot trophic ulcer treatment.
References
1. Veves A., Giurini J., LoGerfo F. The Diabetic Foot. 2nd еd. A. Veves (ed.). Humana Press, 2006.
2. Международное соглашение по диабетической стопе. Международная рабочая группа по диабетической стопе. М.: Берег, 2000.
3. Bernard F., Barrault C., Juchaux F. et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing. J. Wound Care 2005; 14: 215–220.
4. Удовиченко О.В., Грекова Н.М. Диабетическая стопа: Руководство для врачей. М.: Практическая медицина, 2010.
5. Токмакова А.Ю., Страхова Г.Ю., Арбузова М.И. Особенности хронических ран у больных сахарным диабетом и пути их коррекции. Эндокринная хирурния. 2007;(1): 38–42.
6. Храмилин В.Н. Применение перевязочных средств на основе липидо-коллоидной технологии в местном лечении синдрома диабетической стопы. Сахарный диабет. 2010;(3):129–132.
7. Boulton A. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004; 47: 1343–1353.
8. Carsin H., Wassermann D., Pannier M. et al. A silver sulphadiazine-impregnated lipidocolloid wound dressing to treat second-degree burns. J. Wound Care 2004; 13: 145–148.
9. Letouze A., Voinchet V., Hoecht B. et al. Using a new lipidocolloid dressing in paediatric wounds: results of French and German clinical studies. J. Wound Care 2004; 13: 221–225.
10. Meaume S, Ourabah Z, Cartier H. et al. Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers. J. Wound Care 2005; 14: 329–334.
Review
For citations:
Bregovskyi V.B. Wound bandage basing on lipidocolloid technology application experience in outpatient treatment of foot trophic ulcer. Endocrine Surgery. 2011;5(1):29-33. (In Russ.) https://doi.org/10.14341/2306-3513-2011-1-29-33
Views:
398
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
